Axsome Therapeutics

Patent cliffs & loss of exclusivity

Axsome Therapeutics is a New York biopharmaceutical company that develops and commercializes medicines for central nervous system disorders, including depression, excessive daytime sleepiness and migraine, and develops additional therapies for neurological and psychiatric conditions.

Company

AngelList URLhttps://angel.co/axsome-therapeutics
CAGE Code7J7H1
Legal NameAxsome Therapeutics, Inc.
Company Operating StatusActive
Contact Page URLhttps://www.axsome.com/contact-us
Crunchbase URLhttps://www.crunchbase.com/organization/axsome-therapeutics
Email format{f}{last}
Fax Number+1 (212) 320-0245

3 upcoming patent cliffs

DrugIngredientTypeCliff
  1. AUVELITYBUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDESmall mol.Jan 2043
  2. AUVELITYBUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDESmall mol.Nov 2043
  3. SYMBRAVOMELOXICAM; RIZATRIPTAN BENZOATESmall mol.Mar 2045

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.